 <h1>Fluzone Quadrivalent Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>influenza virus vaccine, inactivated</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about influenza virus vaccine, inactivated. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Fluzone Quadrivalent.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to influenza virus vaccine, inactivated: intramuscular solution</i></p><p>Other dosage forms:</p><ul><li>suspension</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, influenza virus vaccine, inactivated (the active ingredient contained in Fluzone Quadrivalent) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking influenza virus vaccine, inactivated:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Cough</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>hives, itching, or skin rash</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>tightness in the chest</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of influenza virus vaccine, inactivated may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Difficulty with moving</li>
<li>headache</li>
<li>joint pain</li>
<li>muscle aching or cramping</li>
<li>muscle pains or stiffness</li>
<li>nausea</li>
<li>pain at the injection site</li>
<li>swollen joints</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chills</li>
<li>redness, bruising, or swelling at the injection site</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to influenza virus vaccine, inactivated: intradermal suspension, intramuscular solution, intramuscular suspension, nasal spray</i></p><h3>General</h3><p>The most common adverse events were local reactions, myalgia, and headache.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Tenderness (89%), erythema/redness (76.4%), pain (73.8%), induration (58.4%), swelling (56.8%), injection-site pruritus (46.9%), itching (28%), bruising (18%), injection-site ecchymosis (14.9%), mass (11%)</p>
<p><b>Common</b> (1% to 10%): Reaction, hemorrhage</p>
<p><b>Postmarketing reports</b>: Cellulitis, injection site inflammation, injection site sterile abscess<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Crying abnormal (41.2%), malaise (38%), fever (16%)</p>
<p><b>Common</b> (1% to 10%): Chest tightness</p>
<p><b>Rare</b> (less than 0.1%): Death</p>
<p><b>Postmarketing reports</b>: Hot flashes/flushes<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Myalgia (40%)</p>
<p><b>Common</b> (1% to 10%): Chills/shivering, back pain</p>
<p><b>Postmarketing reports</b>: Muscle weakness, arthritis, arthralgia, myasthenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (40%), drowsiness (37.7%), lethargy (14%)</p>
<p><b>Common</b> (1% to 10%): Migraine</p>
<p><b>Postmarketing reports</b>: Neuralgia, paresthesia, convulsions (including febrile seizures), encephalopathy, neuritis or neuropathy, transverse myelitis, Guillain-Barre syndrome, abnormal gait, dizziness, hypoesthesia, hypokinesia, tremor, somnolence, syncope, facial or cranial nerve paralysis, encephalopathy, limb paralysis, confusion, paralysis (including Bell's Palsy), vertigo, exacerbation of symptoms of mitochondrial encephalomyopathy (Leigh syndrome), meningitis, eosinophilic meningitis, vaccine-associated encephalitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Runny nose/nasal congestion (58%), cough (15%), upper respiratory tract infection (13%)</p>
<p><b>Common</b> (1% to 10%): Sore throat, cough, oropharyngeal pain, rhinorrhea, wheezing, pharyngolaryngeal pain, nasopharyngitis</p>
<p><b>Postmarketing reports</b>: Rhinitis, laryngitis, dyspnea, dysphonia, bronchospasm, throat tightness, pharyngitis, epistaxis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Vomiting (15%), nausea (14.9%) diarrhea (13%)</p>
<p><b>Postmarketing reports</b>: Dysphagia, abdominal pain, swelling of the mouth, throat, and/or tongue<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Loss of appetite (33.3%), decreased appetite (21%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Irritability (54%)</p>
<p><b>Postmarketing reports</b>: Insomnia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reactions including anaphylactic shock, serum sickness, and death; Stevens-Johnson syndrome<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection, influenza-like illness</p>
<p><b>Postmarketing reports</b>: Cellulitis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Facial swelling</p>
<p><b>Postmarketing reports</b>: Pruritus, urticaria, rash, angioedema, sweating, flushing, pallor, rash, erythema multiforme<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Reddened eyes</p>
<p><b>Postmarketing reports</b>: Eye pain, photophobia, conjunctivitis, eye irritation, eye swelling, eyelid swelling, ocular hyperemia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Transient thrombocytopenia, lymphadenopathy<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Pleuropericarditis with effusions</p>
<p><b>Postmarketing reports</b>: Tachycardia, pericarditis, vasculitis, vasodilation/flushing<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Postmarketing reports</b>: Vasculitis with transient renal involvement<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysmenorrhea<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Fluarix 2014-2015 (influenza virus vaccine, inactivated)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. "Product Information. FluLaval Quadrivalent 2015-2016 (influenza virus vaccine, inactivated)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_3">3. "Product Information. Afluria 2015-2016 (influenza virus vaccine, inactivated)." bioCSL Inc, King of Prussia, PA. </p><p id="ref_4">4. "Product Information. Fluvirin 2015-2016 (influenza virus vaccine, inactivated)." Novartis Vaccines &amp; Diagnostics Inc, Cambridge, MA. </p><p id="ref_5">5. "Product Information. Fluzone Quadrivalent (influenza virus vaccine, inactivated)." Sanofi Pasteur, Toronto, IA. </p><p id="ref_6">6. "Product Information. Fluzone High-Dose 2015-2016 (influenza virus vaccine, inactivated)." sanofi pasteur, Swiftwater, PA. </p><p id="ref_7">7. "Product Information. Flublok 2015-2016 (influenza virus vaccine, inactivated)." Protein Sciences Corporation, Meriden, CT. </p><p id="ref_8">8. "Product Information. FluLaval 2014-2015 (influenza virus vaccine, inactivated)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_9">9. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_10">10. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_11">11. "Product Information. Fluzone Intradermal 2014-2015 (influenza virus vaccine, inactivated)." sanofi pasteur, Swiftwater, PA. </p><p id="ref_12">12. "Product Information. Agriflu (influenza virus vaccine, inactivated)." Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_13">13. "Product Information. Flucelvax 2015-2016 (influenza virus vaccine, inactivated)." Novartis Vaccines &amp; Diagnostics Inc, Cambridge, MA. </p><p id="ref_14">14. "Product Information. Fluarix Quadrivalent 2015-2016 (influenza virus vaccine, inactivated)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_15">15. "Product Information. Fluzone Influenza Vaccine (influenza virus vaccine)." Connaught, Swiftwater, PA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Fluzone Quadrivalent (influenza virus vaccine, inactivated)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: viral vaccines</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Fluzone Quadrivalent 2020-2021 injection</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Afluria, Fluad, Flucelvax Quadrivalent, Fluarix Quadrivalent, ... +7 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Influenza Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to influenza virus vaccine, inactivated: intradermal suspension, intramuscular solution, intramuscular suspension, nasal spray</i></p><h3>General</h3><p>The most common adverse events were local reactions, myalgia, and headache.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Tenderness (89%), erythema/redness (76.4%), pain (73.8%), induration (58.4%), swelling (56.8%), injection-site pruritus (46.9%), itching (28%), bruising (18%), injection-site ecchymosis (14.9%), mass (11%)</p><p><b>Common</b> (1% to 10%): Reaction, hemorrhage</p><p><b>Postmarketing reports</b>: Cellulitis, injection site inflammation, injection site sterile abscess<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Crying abnormal (41.2%), malaise (38%), fever (16%)</p><p><b>Common</b> (1% to 10%): Chest tightness</p><p><b>Rare</b> (less than 0.1%): Death</p><p><b>Postmarketing reports</b>: Hot flashes/flushes<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Myalgia (40%)</p><p><b>Common</b> (1% to 10%): Chills/shivering, back pain</p><p><b>Postmarketing reports</b>: Muscle weakness, arthritis, arthralgia, myasthenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (40%), drowsiness (37.7%), lethargy (14%)</p><p><b>Common</b> (1% to 10%): Migraine</p><p><b>Postmarketing reports</b>: Neuralgia, paresthesia, convulsions (including febrile seizures), encephalopathy, neuritis or neuropathy, transverse myelitis, Guillain-Barre syndrome, abnormal gait, dizziness, hypoesthesia, hypokinesia, tremor, somnolence, syncope, facial or cranial nerve paralysis, encephalopathy, limb paralysis, confusion, paralysis (including Bell's Palsy), vertigo, exacerbation of symptoms of mitochondrial encephalomyopathy (Leigh syndrome), meningitis, eosinophilic meningitis, vaccine-associated encephalitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Runny nose/nasal congestion (58%), cough (15%), upper respiratory tract infection (13%)</p><p><b>Common</b> (1% to 10%): Sore throat, cough, oropharyngeal pain, rhinorrhea, wheezing, pharyngolaryngeal pain, nasopharyngitis</p><p><b>Postmarketing reports</b>: Rhinitis, laryngitis, dyspnea, dysphonia, bronchospasm, throat tightness, pharyngitis, epistaxis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Vomiting (15%), nausea (14.9%) diarrhea (13%)</p><p><b>Postmarketing reports</b>: Dysphagia, abdominal pain, swelling of the mouth, throat, and/or tongue<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Loss of appetite (33.3%), decreased appetite (21%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Irritability (54%)</p><p><b>Postmarketing reports</b>: Insomnia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reactions including anaphylactic shock, serum sickness, and death; Stevens-Johnson syndrome<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection, influenza-like illness</p><p><b>Postmarketing reports</b>: Cellulitis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Facial swelling</p><p><b>Postmarketing reports</b>: Pruritus, urticaria, rash, angioedema, sweating, flushing, pallor, rash, erythema multiforme<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Reddened eyes</p><p><b>Postmarketing reports</b>: Eye pain, photophobia, conjunctivitis, eye irritation, eye swelling, eyelid swelling, ocular hyperemia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Transient thrombocytopenia, lymphadenopathy<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Pleuropericarditis with effusions</p><p><b>Postmarketing reports</b>: Tachycardia, pericarditis, vasculitis, vasodilation/flushing<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Postmarketing reports</b>: Vasculitis with transient renal involvement<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysmenorrhea<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Fluarix 2014-2015 (influenza virus vaccine, inactivated)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. "Product Information. FluLaval Quadrivalent 2015-2016 (influenza virus vaccine, inactivated)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_3">3. "Product Information. Afluria 2015-2016 (influenza virus vaccine, inactivated)." bioCSL Inc, King of Prussia, PA. </p><p id="ref_4">4. "Product Information. Fluvirin 2015-2016 (influenza virus vaccine, inactivated)." Novartis Vaccines &amp; Diagnostics Inc, Cambridge, MA. </p><p id="ref_5">5. "Product Information. Fluzone Quadrivalent (influenza virus vaccine, inactivated)." Sanofi Pasteur, Toronto, IA. </p><p id="ref_6">6. "Product Information. Fluzone High-Dose 2015-2016 (influenza virus vaccine, inactivated)." sanofi pasteur, Swiftwater, PA. </p><p id="ref_7">7. "Product Information. Flublok 2015-2016 (influenza virus vaccine, inactivated)." Protein Sciences Corporation, Meriden, CT. </p><p id="ref_8">8. "Product Information. FluLaval 2014-2015 (influenza virus vaccine, inactivated)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_9">9. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_10">10. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_11">11. "Product Information. Fluzone Intradermal 2014-2015 (influenza virus vaccine, inactivated)." sanofi pasteur, Swiftwater, PA. </p><p id="ref_12">12. "Product Information. Agriflu (influenza virus vaccine, inactivated)." Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_13">13. "Product Information. Flucelvax 2015-2016 (influenza virus vaccine, inactivated)." Novartis Vaccines &amp; Diagnostics Inc, Cambridge, MA. </p><p id="ref_14">14. "Product Information. Fluarix Quadrivalent 2015-2016 (influenza virus vaccine, inactivated)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_15">15. "Product Information. Fluzone Influenza Vaccine (influenza virus vaccine)." Connaught, Swiftwater, PA. </p><h2>More about Fluzone Quadrivalent (influenza virus vaccine, inactivated)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: viral vaccines</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Fluzone Quadrivalent 2020-2021 injection</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Influenza Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>